Dr. Reiss is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6677 W Thunderbird Rd
Ste F101
Glendale, AZ 85306Phone+1 623-878-3939Fax+1 623-878-5567
Summary
- Dr. George Reiss is an experienced Ophthalmologist based in Glendale, AZ with subspecialties in anterior segment, cataract, and glaucoma related disorders. He received his medical education from notable institutions including University of Illinois College of Medicine at Chicago, Stony Brook University Health Sciences Center School of Medicine, Southern Connecticut State University, University of Minnesota, and Mayo Clinic College of Medicine and Science. His career has included roles such as Team Ophthalmologist for several hockey clubs and consultant roles for NBA and veteran's hospitals. Dr. Reiss has published extensively in his field and participated in several clinical trials, predominantly focused on glaucoma. His honors and awards include CMS Meaningful Use Stage 1 Certification and Cheeseborough-Ponds Chemistry Scholarship.
Education & Training
- University of Illinois College of Medicine at ChicagoResidency, Ophthalmology, 1988 - 1988
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Ophthalmology, 1983 - 1986
- University of MinnesotaMS, Biomedical Research, 1982 - 1983
- NYU Grossman Long Island School of MedicineInternship, Internal Medicine, 1981 - 1982
- Stony Brook University Health Sciences Center School of MedicineClass of 1981
- Southern Connecticut State UniversityBA, Biochemistry, Magna Cum Laude, 1973 - 1977
Certifications & Licensure
- AZ State Medical License 1987 - 2026
- MN State Medical License 1982 - 1993
- IL State Medical License 1988 - 1990
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification IO Practiceware EHR, IO Practiceware, Inc., 2013
- Who's Who in American Colleges and Universities 1977
- Cheeseborough-Ponds Chemistry Scholarship 1977
- Join now to see all
Clinical Trials
- Memantine in Patients With Chronic Glaucoma Start of enrollment: 2000 Mar 01
- Study of an Implantable Device for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery Start of enrollment: 2009 Sep 01
- Open-angle Glaucoma Subjects on One Ocular Hypotensive Medication Randomized to Treatment With Two Trabecular Micro-bypass Stents or Selective Laser Trabeculoplasty Start of enrollment: 2011 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 160 citationsProspective, Randomized, Controlled Pivotal Trial of an Ab Interno Implanted Trabecular Micro-Bypass in Primary Open-Angle Glaucoma and Cataract: Two-Year Results.Thomas W. Samuelson, Steven R. Sarkisian, David M. Lubeck, Michael C. Stiles, Yi-Jing Duh
Ophthalmology. 2019-03-14 - 95 citationsAscorbic Acid Levels in the Aqueous Humor of Nocturnal and Diurnal MammalsGeorge R. Reiss, Peter G. Werness, Paul E. Zollman, Richard F. Brubaker
Archives of Ophthalmology. 1986-05-01 - 43 citationsSafety and Effectiveness of CyPass Supraciliary Micro-Stent in Primary Open-Angle Glaucoma: 5-Year Results from the COMPASS XT Study.George R. Reiss, Bill Clifford, Steven D. Vold, Jonathan He, Cody Hamilton
American Journal of Ophthalmology. 2019-08-01
Journal Articles
- Titanium Sapphire Laser Trabeculoplasty Opens a New Frontier in Laser TrabeculoplastyReiss, GR, Glaucoma Today, 3/1/2012
- What are the Current Strengths of Glaucoma Care?Reiss, GR, Glaucoma Today, 12/1/2010
- The use of Carbonic Anhydrase Inhibitors in patients who give a history of allergy to Sulfa-related agents.Reiss, GR, Noecker, R, American Glaucoma Society Meeting, San Antonio, 3/2000
- Join now to see all
Books/Book Chapters
Lectures
- Eye Injuries and First Line Treatments7/1/2007
- Vision Correction Options in Athletes8/1/2004
- The use of Carbonic Anyhdrase Inhibitors in patients who give a history of allergy to Sulfa-related agents3/1/2000
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: